MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4873 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-01-24 (cfo.com)
CFOs On the Move: Week ending Jan. 24 |
Abnormal Security names a new finance chief as it preps for an IPO, Birkenstock appoints a new CFO and Medtronic hires its new CFO from Renault.
Read more
2025-01-22 (globalbankingandfinance.com)
Medtronic appoints Renault's exec Thierry Piéton as finance chief
(Reuters) - Medtronic said on Monday it will appoint Renault's finance chief Thierry Piéton as its Chief Financial Officer, effective March 3. Piéton will succeed Gary Corona, who has been serving as
Read more
2025-01-21 (beckersspine.com)
Medtronic names new CFO
Medtronic appoints Thierry Piéton as CFO, bringing in a seasoned financial leader with experience at Renault Group.
Read more
2025-01-21 (tipranks.com)
Medtronic Appoints Thierry Pieton as New CFO - TipRanks.com
An announcement from Medtronic ( ($MDT) ) is now available. Medtronic announced the appointment of Thierry Pieton as Chief Financial Officer effective March 3, 2025...
Read more
2025-01-06 (finanznachrichten.de)
Medtronic plc: Medtronic appoints Thierry Piéton as Chief Financial Officer
GALWAY, Ireland, Jan. 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been
Read more
2024-09-30 (quantisnow.com)
Volition Appoints Dr. Ethel Rubin as an Independent Director
HENDERSON, Nev., Sept. 30, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, has appointed Dr. Ethel Rubin to its board of directors, as an independent director, effective September 30, 2024. Dr. Rubin has also been appointed as a member of the
Read more
2024-09-25 (huntscanlon.com)
McDermott + Bull Assists Inari Medical with CTO Search
Chief technology officers are crucial because they drive the technological vision and strategy of an organization, ensuring that technology investments align with business goals, according to executive recruiters.
Read more
2024-09-25 (prweek.com)
Medtronic hires Jane Di Leo to lead comms in the Americas
Medtronic hires Jane Di Leo to lead comms in the Americas. From PR Week
Read more
2024-09-14 (marketwirenews.com)
ATEC Reports Second Quarter 2024 Financial Results...
Surgical revenue grew 27% and drove total revenue growth of 25% to $146 million Full-year revenue and profitability guidance increased Alphatec.
Read more